Qlif-23. functional outcome, symptom burden and survival vary by molecular subgroup in patients with anaplastic glioma

CONCLUSION:In these pilot data, unfavorable molecular subgroups had worse survival and baseline neurologic dysfunction, but experienced significant recovery of physical and cognitive function after treatment. Whether tumor or patient-related factors account for this selective recovery will be explored in future studies.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Kim, M., Hervey-Jumper, S., Tao, Y., Schipper, M., Orringer, D. A., Heth, J. A., Junck, L., Mammoser, A., Kim, C., Lawrence, T., Tsien, C., Armstrong, T. S. Tags: QUALITY OF LIFE Source Type: research